68189 results
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm (updated)
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,
, Revision: 12, Authorised, Last updated: 22/06/2021
-
List item
Human medicine European public assessment report (EPAR): Atripla (updated)
efavirenz, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 13/12/2007, Revision: 35, Authorised, Last updated: 22/06/2021 -
List item
Human medicine European public assessment report (EPAR): Pradaxa (updated)
Dabigatran etexilate mesilate, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 17/03/2008,
, Revision: 34, Authorised, Last updated: 22/06/2021
-
List item
Human medicine European public assessment report (EPAR): Levetiracetam Actavis (updated)
levetiracetam, Epilepsy
Date of authorisation: 03/10/2011,, Revision: 16, Authorised, Last updated: 22/06/2021
-
List item
Human medicine European public assessment report (EPAR): Waylivra (updated)
Volanesorsen sodium, Hyperlipoproteinemia Type I
Date of authorisation: 03/05/2019,
, 
, 
, Revision: 3, Authorised, Last updated: 22/06/2021
-
List item
Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)
Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016, Revision: 12, Authorised, Last updated: 22/06/2021 -
List item
Human medicine European public assessment report (EPAR): Azomyr (updated)
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 15/01/2001, Revision: 46, Authorised, Last updated: 22/06/2021 -
List item
Human medicine European public assessment report (EPAR): Brimica Genuair (updated)
formoterol fumarate dihydrate, aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 19/11/2014,, Revision: 12, Authorised, Last updated: 22/06/2021
-
List item
Human medicine European public assessment report (EPAR): Xromi (updated)
hydroxycarbamide, Anemia, Sickle Cell
Date of authorisation: 01/07/2019, Revision: 2, Authorised, Last updated: 22/06/2021